U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H25ClN2O3.ClH
Molecular Weight 377.306
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETICLOPRIDE HYDROCHLORIDE

SMILES

Cl.CCN1CCC[C@H]1CNC(=O)C2=C(O)C(CC)=CC(Cl)=C2OC

InChI

InChIKey=HFJFXXDHVWLIKX-YDALLXLXSA-N
InChI=1S/C17H25ClN2O3.ClH/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2;/h9,12,21H,4-8,10H2,1-3H3,(H,19,22);1H/t12-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C17H25ClN2O3
Molecular Weight 340.845
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Eticlopride {2S(−)-3-chloro-5-ethyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-hydroxy-2-methoxybenzamide} is an antagonist at dopamine D2 and D3 receptors. It is widely used for in vivo, in vitro, and ex vivo examination of D2/D3 receptors densities and function. Eticlopride exerts antipsychotic activity in animals.

CNS Activity

Curator's Comment: Eticlopride is CNS active in animals. No human data available.

Originator

Sources: de Paulis T, Hall H, Ogren SO, Wagner A. Synthesis, crystal structure and antidopaminergic properties of eticlopride (FLB 131) Eur J Med Chem. 1985;29:273–276

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.5 nM [Ki]
0.16 nM [Ki]
Target ID: P14416
Gene ID: 1813.0
Gene Symbol: DRD2
Target Organism: Homo sapiens (Human)
0.08 nM [Ki]
Target ID: P35462
Gene ID: 1814.0
Gene Symbol: DRD3
Target Organism: Homo sapiens (Human)
0.134 nM [Ki]
7.0 null [pKi]
PubMed

PubMed

TitleDatePubMed
Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma.
2015-07-15
Screening of a chemical library reveals novel PXR-activating pharmacologic compounds.
2015-01-05
Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.
2010-06-16
Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation.
2010-03
The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.
2006-10-30
Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior.
2006-10-23
Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
2006-03
Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat.
2005-11
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
2005-08
Glutamic acid decarboxylase 67 mRNA regulation in two globus pallidus neuron populations by dopamine and the subthalamic nucleus.
2004-03-24
Effects of dopamine antagonists on alfentanil-induced locomotor activity in horses.
2003-07
Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum.
2003-07
Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.
2002-04-01
Differential effects of D1- and D2-like compounds on cocaine self-administration in Lewis and Fischer 344 inbred rats.
2001-11
The effects of benzamide analogues on cocaine self-administration in rhesus monkeys.
1999-11
Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions.
1999-01-01
Involvement of dopamine D2 receptors in the effect of cocaine on sexual behaviour and stretching-yawning of male rats.
1997-06
Bromocriptine transcriptionally activates the multidrug resistance gene (pgp2/mdr1b) by a novel pathway.
1997-04-25
Cerebrocortical Fos expression following dopaminergic stimulation: D1/D2 synergism and its breakdown.
1996-07-22
Is clozapine selective for the dopamine D4 receptor?
1995
Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
1994-01-01
Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.
1994-01
Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats.
1990-10
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:20:39 GMT 2025
Edited
by admin
on Mon Mar 31 22:20:39 GMT 2025
Record UNII
HJ2CAH4TZ1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ETICLOPRIDE HYDROCHLORIDE
Common Name English
NSC-759849
Preferred Name English
BENZAMIDE, 3-CHLORO-5-ETHYL-N-(((2S)-1-ETHYL-2-PYRROLIDINYL)METHYL)-6-HYDROXY-2-METHOXY-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
CAS
97612-24-3
Created by admin on Mon Mar 31 22:20:39 GMT 2025 , Edited by admin on Mon Mar 31 22:20:39 GMT 2025
PRIMARY
FDA UNII
HJ2CAH4TZ1
Created by admin on Mon Mar 31 22:20:39 GMT 2025 , Edited by admin on Mon Mar 31 22:20:39 GMT 2025
PRIMARY
EPA CompTox
DTXSID4045769
Created by admin on Mon Mar 31 22:20:39 GMT 2025 , Edited by admin on Mon Mar 31 22:20:39 GMT 2025
PRIMARY
PUBCHEM
57266
Created by admin on Mon Mar 31 22:20:39 GMT 2025 , Edited by admin on Mon Mar 31 22:20:39 GMT 2025
PRIMARY
DRUG BANK
DBSALT002889
Created by admin on Mon Mar 31 22:20:39 GMT 2025 , Edited by admin on Mon Mar 31 22:20:39 GMT 2025
PRIMARY
NSC
759849
Created by admin on Mon Mar 31 22:20:39 GMT 2025 , Edited by admin on Mon Mar 31 22:20:39 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE